跳至主要内容
临床试验/NCT07545057
NCT07545057尚未招募不适用

A Feasibility Study on Synchronous Biopsy and Radiofrequency Ablation for Pulmonary Nodules Under Robotic-Assisted Bronchoscopy: A Prospective, Single-Arm, Open-Label Clinical Study:ROBUST Study

Shanghai Chest Hospital1 个研究点 分布在 1 个国家目标入组 76 人开始时间: 2026年5月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
尚未招募
入组人数
76
试验地点
1
主要终点
Technical success rate (at the lesion level)

研究概览

简要总结

This is a prospective, single-arm, open-label clinical study. The primary study objective is to evaluate the feasibility of synchronous biopsy and radiofrequency ablation for pulmonary nodules under robotic-assisted bronchoscopy.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 100 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age ≥ 18 years old;
  • Chest CT indicates pulmonary nodules, highly suspected of being malignant;
  • Size of pulmonary nodules: 8 mm < maximum diameter ≤ 30 mm, and the number of pulmonary nodules requiring intervention ≤ 3;
  • Preoperative imaging evaluation indicates no clear lymph node metastasis or distant metastasis (cT1N0M0);
  • Multidisciplinary evaluation shows that the patient cannot tolerate surgery and radiotherapy, or the patient refuses surgery and radiotherapy after full informed consent;
  • The patient understands and agrees to receive synchronous biopsy and ablation treatment under robotic-assisted bronchoscopy and signs a written informed consent form.

排除标准

  • Patients who cannot tolerate general anesthesia due to advanced age or severe cardiopulmonary diseases, or other reasons;
  • The target nodule has been diagnosed as a malignant tumor or metastasis;
  • Patients with severe bleeding tendency or uncorrectable coagulation disorder (platelet count < 50×10^9 /L, prothrombin time > 18s, prothrombin activity < 40%);
  • Severe pulmonary fibrosis and pulmonary hypertension;
  • Anticoagulant or anti-platelet drugs have not been discontinued for the required time before surgery;
  • Implanted cardiac pacemaker, defibrillator, or other electronic implants;
  • Presence of important blood vessels that cannot be avoided along the biopsy path;
  • Other conditions that the investigators consider not suitable for the patient to participate in this study.

研究组 & 干预措施

Patients with clinically suspected malignant pulmonary nodules requiring diagnosis and treatment

Experimental

干预措施: Robotic-assisted bronchoscopy-guided synchronous biopsy and radiofrequency ablation for pulmonary nodules (Procedure)

结局指标

主要结局

Technical success rate (at the lesion level)

时间窗: 6 months

The proportion of lesions with a definite malignant diagnosis by synchronous biopsy and effective ablation (with postoperative immediate imaging indicating that the ablation range is at least 5 mm larger than the boundary of the target lesion) among the lesions ultimately diagnosed as malignant.

次要结局

  • Biopsy diagnostic yield (at the lesion level)(6 months)
  • Sensitivity of malignancy (at the lesion level)(6 months)
  • Complete ablation rate (at the lesion level)(3 months, 1 year, 2 years, 3 years, and 5 years)
  • Local progression-free period (at the lesion level)(3 months, 1 year, 2 years, 3 years, and 5 years)
  • Progression-free survival(3 months, 1 year, 2 years, 3 years, and 5 years)
  • Overall survival(3 months, 1 year, 2 years, 3 years, and 5 years)
  • Pulmonary function indicators (at the patient level)(1 year)
  • The incidence of procedure-related complications (at the patient level)(1 month)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jiayuan Sun

Director, Department of Respiratory Endoscopy

Shanghai Chest Hospital

研究点 (1)

Loading locations...

相似试验

Robotic-Assisted Bronchoscopy-Guided Synchronous... | 临床试验